Trial intelligence / Profile preview

Allopurinol and Cardiac Function Pilot Study in Idiopathic Dilated Cardiomyopathy

NCT00281255Phase 2Withdrawn

Sponsor
University of Pennsylvania
Start
Jun 2003
Primary completion
Jun 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in dilated cardiomyopathy (DCM) comparing allopurinol with placebo (2 arms). Primary endpoint: Radial and circumferential strain after infusion of allopurinol as measured by cardiac MRI at Day 1. Planned start Jun 2003; status: withdrawn.

02

Drugs

allopurinol
03

Conditions

dilated cardiomyopathy (DCM)

Beyond the preview

Go deeper on NCT00281255.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00281255.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call